Prognostic Stage III Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Trastuzumab deruxtecan (DB14962)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs